← Leaderboards
Thimmasettappa Thippeswamy
Iowa State University
$6,425,429
Attributed
$6,425,429
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,425,429 · 6
By mechanism
U01$3,894,577 · 1
R21$1,612,852 · 4
R01$918,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Epilepsy”
- Nanthia A Suthana · University Of California Los Angeles$12,946,372
- Shadi Dayeh · University Of California, San Diego$11,849,859
- Laura Scheinfeldt · Coriell Institute For Medical Research$7,339,122
- Yu Wang · University Of Michigan At Ann Arbor$6,727,888
- Benjamin E Deverman · Broad Institute, Inc.$6,462,832
- Ingo Helbig · Children'S Hosp Of Philadelphia$5,948,097
Research focus
EpilepsyRattusCytokinePharmaceutical PreparationsBrainNerve DegenerationSerumPreventSeizuresAtropineAcuteNerve AgentHourExposure ToOrganophosphatesStatus EpilepticusNeuroinflammationKainateOximesOralMonitorMedical CountermeasureNeuroprotective AgentsNeurotoxicity
Grant awards (15)
Saracatinib and 1400W Counteract Nerve Agents-Induced Long-Term Neurotoxicity$758,516
U01 · FY2025 · NS · contact PI
Mechanisms of Neurodegeneration in a Nerve Agent Model$459,000
R01 · FY2025 · NS · contact PI
Investigating the efficacy and mechanistic pathways of saracatinib, a medical countermeasure, in a pediatric rat DFP model$146,426
U01 · FY2025 · NS · contact PI
Saracatinib and 1400W Counteract Nerve Agents-Induced Long-Term Neurotoxicity$756,847
U01 · FY2024 · NS · contact PI
Mechanisms of Neurodegeneration in a Nerve Agent Model$459,000
R01 · FY2024 · NS · contact PI
Saracatinib and 1400W Counteract Nerve Agents-Induced Long-Term Neurotoxicity$758,641
U01 · FY2023 · NS · contact PI
Saracatinib and 1400W Counteract Nerve Agents-Induced Long-Term Neurotoxicity$746,842
U01 · FY2022 · NS · contact PI
Mitoapocynin, a novel NOX2 inhibitor, mitigates nerve agents induced longterm neurotoxicity$179,548
R21 · FY2022 · NS · contact PI
Saracatinib and 1400W Counteract Nerve Agents-induced Long-term Neurotoxicity$727,305
U01 · FY2021 · NS · contact PI
Mitoapocynin, a novel NOX2 inhibitor, mitigates nerve agents induced longterm neurotoxicity$218,269
R21 · FY2021 · NS · contact PI
Fyn Mediated Neuroinflammatory Signaling in Epileptogenesis and Epilepsy$406,966
R21 · FY2020 · NS · contact PI
Saracatinib Mitigates OP nerve agent-induced Long-term Neurotoxicity$186,707
R21 · FY2020 · NS · contact PI
Saracatinib Mitigates OP nerve agent-induced Long-term Neurotoxicity$225,140
R21 · FY2019 · NS · contact PI
Toxin-specific and symptomatic drugs in combination with novel neuroprotectants effectively counteract DFP-induced long-term neurotoxicity$179,864
R21 · FY2018 · NS · contact PI
Toxin-specific and symptomatic drugs in combination with novel neuroprotectants effectively counteract DFP-induced long-term neurotoxicity$216,358
R21 · FY2017 · NS · contact PI